These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39085881)

  • 1. Accuracy of renovo predictions on variants reclassified over time.
    Bonetti E; Tini G; Mazzarella L
    J Transl Med; 2024 Jul; 22(1):713. PubMed ID: 39085881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning-based reclassification of germline variants of unknown significance: The RENOVO algorithm.
    Favalli V; Tini G; Bonetti E; Vozza G; Guida A; Gandini S; Pelicci PG; Mazzarella L
    Am J Hum Genet; 2021 Apr; 108(4):682-695. PubMed ID: 33761318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant classification changes over time in the clinical molecular diagnostic laboratory setting.
    Hahn E; Mighton C; Fisher Y; Wong A; Di Gioacchino V; Watkins N; Mayers J; Bombard Y; Charames GS; Lerner-Ellis J
    J Med Genet; 2024 Jul; 61(8):788-793. PubMed ID: 38806232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant classification changes over time in BRCA1 and BRCA2.
    Mighton C; Charames GS; Wang M; Zakoor KR; Wong A; Shickh S; Watkins N; Lebo MS; Bombard Y; Lerner-Ellis J
    Genet Med; 2019 Oct; 21(10):2248-2254. PubMed ID: 30971832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reclassification of
    Ha HI; Ryu JS; Shim H; Kong SY; Lim MC
    J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic large-scale application of ClinGen InSiGHT
    Yin X; Richardson M; Laner A; Shi X; Ognedal E; Vasta V; Hansen TVO; Pineda M; Ritter D; den Dunnen JT; Hassanin E; Lyman Lin W; Borras E; Krahn K; Nordling M; Martins A; Mahmood K; Nadeau EAW; Beshay V; Tops C; Genuardi M; Pesaran T; Frayling IM; Capellá G; Latchford A; Tavtigian SV; Maj C; Plon SE; Greenblatt MS; Macrae FA; Spier I; Aretz S
    medRxiv; 2024 May; ():. PubMed ID: 38746299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of hereditary cancer gene variant classifications from ClinVar indicates a need for regular reassessment of clinical assertions.
    Davidson AL; Kondrashova O; Leonard C; Wood S; Tudini E; Hollway GE; Pearson JV; Newell F; Spurdle AB; Waddell N
    Hum Mutat; 2022 Dec; 43(12):2054-2062. PubMed ID: 36095262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
    Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal framework to resolve variants of uncertain significance in
    Biar CG; Pfeifer C; Carvill GL; Calhoun JD
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning models for accurate prioritization of variants of uncertain significance.
    Mahecha D; Nuñez H; Lattig MC; Duitama J
    Hum Mutat; 2022 Apr; 43(4):449-460. PubMed ID: 35143088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
    Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
    Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a Cancer Gene Variant Reclassification Program Over a 20-Year Period.
    Esterling L; Wijayatunge R; Brown K; Morris B; Hughes E; Pruss D; Manley S; Bowles KR; Ross TS
    JCO Precis Oncol; 2020; 4():. PubMed ID: 32923914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ClinVar and HGMD genomic variant classification accuracy has improved over time, as measured by implied disease burden.
    Sharo AG; Zou Y; Adhikari AN; Brenner SE
    Genome Med; 2023 Jul; 15(1):51. PubMed ID: 37443081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinterpretation of common pathogenic variants in ClinVar revealed a high proportion of downgrades.
    Xiang J; Yang J; Chen L; Chen Q; Yang H; Sun C; Zhou Q; Peng Z
    Sci Rep; 2020 Jan; 10(1):331. PubMed ID: 31942019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates.
    Zouk H; Yu W; Oza A; Hawley M; Vijay Kumar PK; Koch C; Mahanta LM; Harley JB; Jarvik GP; Karlson EW; Leppig KA; Myers MF; Prows CA; Williams MS; Weiss ST; Lebo MS; Rehm HL
    Genet Med; 2022 Feb; 24(2):454-462. PubMed ID: 34906510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
    Kim JH; Park S; Park HS; Park JS; Lee ST; Kim SW; Lee JW; Lee MH; Park SK; Noh WC; Choi DH; Han W; Jung SH
    Sci Rep; 2021 Apr; 11(1):8485. PubMed ID: 33875706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study of clinical impact of variant of uncertain significance reclassification in breast, ovarian and colorectal cancer susceptibility genes.
    Makhnoon S; Levin B; Ensinger M; Mattie K; Volk RJ; Zhao Z; Mendoza T; Shete S; Samiian L; Grana G; Grainger A; Arun B; Shirts BH; Peterson SK
    Cancer Med; 2023 Feb; 12(3):2875-2884. PubMed ID: 36426404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of genomic germline variant reclassification on clinical cancer care.
    Slavin TP; Manjarrez S; Pritchard CC; Gray S; Weitzel JN
    Oncotarget; 2019 Jan; 10(4):417-423. PubMed ID: 30728895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.
    Gradishar W; Johnson K; Brown K; Mundt E; Manley S
    Oncologist; 2017 Jul; 22(7):797-803. PubMed ID: 28408614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.